project id: TCGA-ESCA; case submitter id: TCGA-R6-A8WG; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.48; rna integrity number: 7.9; age at index: 60; days to birth: -22093; days to death: 386; ethnicity: hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1953; year of death: 2014; age at diagnosis: 22093; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIA; ajcc clinical t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: No; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 287; days to sample procurement: 0; initial weight: 5.0; sample id: b2dc3377-b856-40d4-b1aa-29a86764e206; sample submitter id: TCGA-R6-A8WG-01A; portion id: 5065cebc-0601-4306-9c84-1919071b48f6; portion submitter id: TCGA-R6-A8WG-01A-11; slide id: 7dfec264-444a-456f-8ec5-61d82657f716; slide submitter id: TCGA-R6-A8WG-01Z-00-DX1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;